Effects of Saccharomyces boulardii on intestinal mucosa
- PMID: 16838119
- DOI: 10.1007/s10620-005-9016-x
Effects of Saccharomyces boulardii on intestinal mucosa
Abstract
Saccharomyces boulardii (S. boulardii) is a non-pathogenic biotherapeutic agent, widely prescribed in a lyophilized form in many countries over the world. S. boulardii acts as a shuttle liberating effective enzymes, proteins and trophic factors during its intestinal transit that improve host immune defenses, digestion, and absorption of nutrients. In addition, S. boulardii secretes during its intestinal transit polyamines, mainly spermine and spermidine that regulate gene expression and protein synthesis. In this review, we will focus on the interactions of the yeast with the host intestinal mucosa.
Similar articles
-
Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines.Pediatr Res. 1994 Oct;36(4):522-7. doi: 10.1203/00006450-199410000-00019. Pediatr Res. 1994. PMID: 7816529
-
Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects?J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):532-3. doi: 10.1097/MPG.0b013e3181e23271. J Pediatr Gastroenterol Nutr. 2010. PMID: 20706146 Review.
-
[Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].MMW Fortschr Med. 2019 Mar;161(Suppl 4):20-24. doi: 10.1007/s15006-019-0290-5. Epub 2019 Mar 20. MMW Fortschr Med. 2019. PMID: 30895510 German.
-
Transduction pathways regulating the trophic effects of Saccharomyces boulardii in rat intestinal mucosa.Scand J Gastroenterol. 2010;45(2):175-85. doi: 10.3109/00365520903453141. Scand J Gastroenterol. 2010. PMID: 19958054
-
Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.World J Gastroenterol. 2019 May 14;25(18):2188-2203. doi: 10.3748/wjg.v25.i18.2188. World J Gastroenterol. 2019. PMID: 31143070 Free PMC article. Review.
Cited by
-
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.ISME J. 2016 Feb;10(2):460-77. doi: 10.1038/ismej.2015.127. Epub 2015 Jul 28. ISME J. 2016. PMID: 26218241 Free PMC article.
-
Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.World J Gastroenterol. 2010 May 7;16(17):2134-45. doi: 10.3748/wjg.v16.i17.2134. World J Gastroenterol. 2010. PMID: 20440854 Free PMC article.
-
Sepsis: mechanisms of bacterial injury to the patient.Scand J Trauma Resusc Emerg Med. 2019 Feb 14;27(1):19. doi: 10.1186/s13049-019-0596-4. Scand J Trauma Resusc Emerg Med. 2019. PMID: 30764843 Free PMC article. Review.
-
The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies.Antibiotics (Basel). 2019 Jan 24;8(1):8. doi: 10.3390/antibiotics8010008. Antibiotics (Basel). 2019. PMID: 30682820 Free PMC article. Review.
-
The role of probiotics and prebiotics in inducing gut immunity.Front Immunol. 2013 Dec 12;4:445. doi: 10.3389/fimmu.2013.00445. Front Immunol. 2013. PMID: 24376446 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources